EDGEWELL PERSONAL CARE Co financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data EDGEWELL PERSONAL CARE Co files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,362	2,298	2,234	2,141	1,950	2,087	2,172	2,252	2,254	2,224
Cost of revenue	1,202	1,173	1,202	1,174	1,069	1,136	1,291	1,311	1,298	1,299
Gross profit	1,160	1,126	1,033	967	881	951	881	941	956	925
Research and development	71.9	67.6	61.1	53.5	55.3	57.8	55.5	58.5	58.4	57.6
Selling, general and administrative								410	430	425
Selling and marketing	337	318	293	251	216	242	238	229	232	247
Operating income				244	176	240	182	227	199	96.6
Interest expense	71.8	69.2	68	62.6	61.2	67.9	71.4	78.5	76.5	73.2
Other non-operating income	-3.2	17.4	1.4	-1.5	-5.4	1.2	13.2	-0.8	-1.9	0.2
Pre-tax income	220	-52.9	164	-390	87.3	147	124	148	121	23.6
Income tax	41.2	-58.6	60.5	-18.1	19.7	29.3	24.6	33	22.3	-1.8
Income from continuing operations	179	5.7
Net income	179	5.7	103	-372	67.6	118	99.5	115	98.6	25.4
EBITDA				338	265	327	272	318	287	185
EPS, basic	3.02	0.10	1.90	-6.88	1.25	2.17	1.87	2.24	1.98	0.53
EPS, diluted	2.99	0.10	1.90	-6.88	1.24	2.13	1.85	2.21	1.97	0.53
Shares, basic (weighted)	59.2	57.3	54.4	54.1	54.3	54.4	53.1	51.2	49.7	47.5
Shares, diluted (weighted)	59.7	57.5	54.5	54.1	54.6	55.2	53.6	51.8	50.1	47.6

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	739	503	266	342	365	479	189	216	209	226
Receivables	261	224	227	206	159	151	137	106	109	138
Inventory	309	334	330	357	314	346	449	492	477	434
Other current assets	3.4	3.3	5.3	3.1	10.2	12.9	25.1	12.3	9.1	11.8
Total current assets	1,452	1,186	951	1,044	984	1,136	942	962	936	996
Property, plant and equipment	486	453	424	396	371	363	346	338	349	295
Lease right-of-use assets					43.5	57.7	50.1	68.5	85.4	73.2
Goodwill	1,420	1,446	1,451	1,033	1,160	1,163	1,322	1,331	1,339	1,137
Intangible assets	1,385	1,072	1,099	913	928	906	997	974	949	828
Other non-current assets	28	31.6	28.2	34.8	98.6	107	107	135	159	179
Total assets	4,772	4,189	3,953	3,421	3,541	3,675	3,713	3,741	3,731	3,756
Accounts payable	197	224	238	223	182	210	229	194	219	220
Accrued liabilities	56	40.6	44.2	51.5	62.6	66.4	51.1	65.4	78.6	52.9
Short-term debt	282	0	185	117	0	0	0
Total current liabilities	868	524	717	660	511	537	540	523	564	566
Long-term debt	1,544	1,525	1,104	1,098	1,238	1,234	1,391	1,361	1,275	1,383
Lease liabilities				0	34.6	46.9	41.5	53.9	69.8	57.1
Other non-current liabilities	275	216	212	259	257	190	175	180	175	136
Total liabilities	2,943	2,447	2,209	2,117	2,108	2,090	2,246	2,200	2,147	2,203
Total debt	1,826	1,525	1,292	1,217	1,250	1,250	1,405	1,372	1,284	1,390
Paid-in capital	1,643	1,623	1,628	1,628	1,632	1,631	1,604	1,594	1,586	1,579
Retained earnings	946	953	1,083	715	782	866	939	1,022	1,090	1,087
Treasury stock	-563	-704	-819	-804	-790	-776	-861	-906	-938	-1,003
Other comprehensive income	-197	-131	-148	-236	-192	-137	-216	-170	-155	-110
Shareholders' equity	1,829	1,742	1,745	1,304	1,439	1,591	1,467	1,541	1,584	1,553
Total equity	1,829	1,742	1,745	1,304	1,439	1,591	1,467	1,541	1,584	1,553
Total liabilities and equity	4,772	4,189	3,953	3,421	3,541	3,675	3,713	3,741	3,731	3,756
Shares outstanding	57.9	56	54	54.2	54.4	54.4	51.6	50.1	48.9	46.5

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	179	5.7	103	-372	67.6	118	99.5	115	98.6	25.4
Depreciation and amortization	92.6	94.4	97.6	93.8	88.8	87.1	89.9	91.4	88	88.8
Stock-based compensation	25.6	22.2	17	17.8	19.2	27.3	23.8	27.5	26.5	24.5
Deferred income tax	11.2	-86.3	3.2	-60	-2.9	9.6	-13.8	-4.5	-9.6	-21.7
Change in receivables	23.3	41.4	-10.7	-1.9	66.3	3.7	-6.6	31	-7.3	-15.3
Change in inventory	28.2	-15.5	-12.3	-35	37.1	-28.8	-111	-32.4	19.7	0.1
Cash from operations	187	314	259	191	233	229	102	-216	-231	118
Capital expenditures	-69.5	-69	-62	-58	-47.7	-56.8	-56.4	-49.5	-56.5	-77
Acquisitions	0	-34	-90.2	0	-234	-0.3	-309	0	0
Cash from investing	-69.5	-84.6	-119	-45.5	-196	-48.7	-355	-50.5	-62.4	-72.9
Debt issued	756	271	550	434	50	0	0	0
Debt repaid	-631	-568	-788	-324	-167	0	0	0
Share buybacks	-197	-165	-124	0	0	-9.2	-125	-75.2	-58.5	-90.2
Dividends paid	0	0		0	0	-25.6	-32.6	-31.5	-30.7	-29.3
Cash from financing	-93.4	-478	-380	-63.8	-18.7	-65.4	-17.6	-147	-179	-30
Exchange rate effect	2.9	13	2.5	-6.1	5.6	-0.4	-19.5	8.6	3.5	1.1
Net change in cash	26.8	-236	-237	75.2	23.1	115	-291	27.7	-7.3	16.6
Free cash flow	117	245	197	133	185	172	45.6	-266	-288	41.4
Interest paid	71.3	66.4	66.6	60.6	56.1	61	68.4	74.3	62.8	73.3
Income taxes paid	28.3	14.4	22	58	24.6	25.4	23.8	45.8	33.5	25.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $27.82 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	39.5%	Gross profit / revenue.
Operating margin	0.8%	Operating income / revenue.
EBITDA margin	3.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-1.5%	Pre-tax income / revenue.
Net margin	-4.2%	Net income / revenue.
FCF margin	2.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.4%	Cash from operations / revenue.
Return on equity (ROE)	-6.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-2.6%	Net income / average total assets.
Return on invested capital (ROIC)	0.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	2.6%	Research and development expense / revenue.
SG&A / revenue	19.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.1%	Capital expenditures / revenue.
D&A / revenue	3.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-1.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-3.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	1.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	1.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-51.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-19.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-11.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-35.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-12.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-6.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-74.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-36.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-17.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-73.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-34.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-15.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow CAGR, 3y	5.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-12.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 3y	-3.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-25.9%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-2.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	1.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	1.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	1.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-5.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-3.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-2.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.84x	Current assets / current liabilities.
Quick ratio	0.86x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.66x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.86x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	35.4%	Total debt / total assets.
Liabilities / assets	58.7%	Total liabilities / total assets.
Net debt	$852.9M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	9.95x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.26x	Operating income / interest expense.
Working capital	$508.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	54.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$480.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.63x	Revenue / average total assets.
Fixed asset turnover	7.67x	Revenue / average property, plant and equipment.
Inventory turnover	3.14x	Cost of revenue / average inventory.
Days inventory	116 days	365 x average inventory / cost of revenue.
Receivables turnover	18.8x	Revenue / average receivables.
Days sales outstanding	19 days	365 x average receivables / revenue.
Days payables	62 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	74 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	56.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$2.00	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$48.15	Revenue / diluted weighted shares.
FCF per share	$1.12	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.60	Cash from operations / diluted weighted shares.
Book value per share	$31.68	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$10.43	Tangible book value / shares outstanding.
Cash per share	$8.62	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	54.2%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	30.2%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.28B	Share price x shares outstanding.
Enterprise value	$2.14B	Market cap + total debt - cash - short-term investments.
P/S	0.57x	Market cap / revenue.
P/B	0.88x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	24.5x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	10.6x	Market cap / cash from operations, when positive.
EV/Sales	0.95x	Enterprise value / revenue.
EV/EBIT	120x	Enterprise value / operating income, when both are positive.
EV/EBITDA	24.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	40.7x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.1%	Free cash flow / market cap.
Earnings yield	-7.3%	Net income / market cap (the inverse of P/E).
Dividend yield	2.2%	Dividends paid over the period / market cap.
Shareholder yield	3.4%	(Dividends paid + share buybacks) / market cap.

What was EDGEWELL PERSONAL CARE Co's revenue in fiscal 2025?

EDGEWELL PERSONAL CARE Co reported revenue of $2.22B for fiscal 2025, 1.3% lower than the year before.

Was EDGEWELL PERSONAL CARE Co profitable in fiscal 2025?

Yes. Net income was $25.4M, a net margin of 1.1%.

How much free cash flow did EDGEWELL PERSONAL CARE Co generate in fiscal 2025?

Cash from operations of $118.4M minus capital expenditures of $77.0M left free cash flow of $41.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to EDGEWELL PERSONAL CARE Co